<DOC>
	<DOCNO>NCT01265524</DOCNO>
	<brief_summary>The purpose study determine effect CLP serum potassium sign symptom fluid overload heart failure patient chronic kidney disease .</brief_summary>
	<brief_title>Evaluation CLP Heart Failure Patients With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Heart failure New York Heart Association ( NYHA ) Classification III IV Hospitalization heart failure decompensation associate fluid overload within last six month Chronic kidney disease Must able understand study procedure willing able provide write informed consent No hospitalization within 4 week Baseline Visit In investigator 's judgment , cardiovascular , renal , hepatic , endocrine , gastrointestinal , neurological disease condition make patient study participation unsafe History presence gastrointestinal condition severe constipation gastrointestinal tract strictures Current dialysis patient , anticipate need dialysis study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>